Publikationen

2024Science advances10 (49) : eado2600

Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies

Nagarathinam K, Scheck A, Labuhn M, Ströh L, Herold E, Veselkova B, Tune S, Cramer J, Rosset S, Vollers S, Bankwitz D, Ballmaier M, Böning H, Roth E, Khera T, Ahsendorf-Abidi H, Dittrich-Breiholz O, Obleser J, Nassal M, Jäck H, Pietschmann T, Correia B, Krey T

2024Microbiology spectrum12 (2) : e0256222

Landscape of protein-protein interactions during hepatitis C virus assembly and release

Matthaei A, Joecks S, Frauenstein A, Bruening J, Bankwitz D, Friesland M, Gerold G, Vieyres G, Kaderali L, Meissner F, Pietschmann T

2022Immunity55 (2) : 341-354.e7

Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization

Weber T, Potthoff J, Bizu S, Labuhn M, Dold L, Schoofs T, Horning M, Ercanoglu M, Kreer C, Gieselmann L, Vanshylla K, Langhans B, Janicki H, Ströh L, Knops E, Nierhoff D, Spengler U, Kaiser R, Bjorkman P, Krey T, Bankwitz D, Pfeifer N, Pietschmann T, Flyak A, Klein F

2022Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz65 (2) : 183-191

Development approaches for vaccines against hepatitis C virus infections

Bankwitz D, Krey T, Pietschmann T

2021Gut70 (9) : 1734-1745

Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies

Bankwitz D, Bahai A, Labuhn M, Doepke M, Ginkel C, Khera T, Todt D, Ströh L, Dold L, Klein F, Klawonn F, Krey T, Behrendt P, Cornberg M, McHardy A, Pietschmann T

2020Science advances6 (45) : eabd3233

Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice

Brown R, Tegtmeyer B, Sheldon J, Khera T, Anggakusuma, Todt D, Vieyres G, Weller R, Joecks S, Zhang Y, Sake S, Bankwitz D, Welsch K, Ginkel C, Engelmann M, Gerold G, Steinmann E, Yuan Q, Ott M, Vondran F, Krey T, Ströh L, Miskey C, Ivics Z, Herder V, Baumgärtner W, Lauber C, Seifert M, Tarr A, McClure C, Randall G, Baktash Y, Ploss A, Thi V, Michailidis E, Saeed M, Verhoye L, Meuleman P, Goedecke N, Wirth D, Rice C, Pietschmann T

2020Journal of virology94 (14) : e01690-19

Correction for Haid et al., "Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System"

Haid S, Grethe C, Bankwitz D, Grunwald T, Pietschmann T

2017Journal of hepatology67 (3) : 480-489

Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity

Bankwitz D, Doepke M, Hueging K, Weller R, Bruening J, Behrendt P, Lee J, Vondran F, Manns M, Bartenschlager R, Pietschmann T

2017mBio8 (3) : e00382-17

Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2

Vasiliauskaite I, Owsianka A, England P, Khan A, Cole S, Bankwitz D, Foung S, Pietschmann T, Marcotrigiano J, Rey F, Patel A, Krey T

2016Hepatology (Baltimore, Md.)64 (6) : 1840-1842

Hepatitis C virus plays hide and seek with neutralizing antibodies

Bankwitz D, Pietschmann T